Literature DB >> 19783528

A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats.

Xabier Buqué1, María José Martínez, Ainara Cano, María E Miquilena-Colina, Carmelo García-Monzón, Patricia Aspichueta, Begoña Ochoa.   

Abstract

We aimed to characterize the primary abnormalities associated with fat accumulation and vulnerability to hepatocellular injury of obesity-related fatty liver. We performed functional analyses and comparative transcriptomics of isolated primary hepatocytes from livers of obese insulin-resistant Zucker rats (comprising mild to severe hepatic steatosis) and age-matched lean littermates, searching for novel genes linked to chronic hepatic steatosis. Of the tested genome, 1.6% was identified as steatosis linked. Overexpressed genes were mainly dedicated to primary metabolism (100%), signaling, and defense/acute phase (approximately 70%); detoxification, steroid, and sulfur metabolism (approximately 65%) as well as cell growth/proliferation and protein synthesis/transformation (approximately 70%) genes were downregulated. The overexpression of key genes involved in de novo lipogenesis, fatty acid and glycerolipid import and synthesis, as well as acetyl-CoA and cofactor provision was paralleled by enhanced hepatic lipogenesis and production of large triacylglycerol-rich VLDL. Greatest changes in gene expression were seen in those encoding the lipogenic malic enzyme (up to 7-fold increased) and cell-to-cell interacting cadherin 17 (up to 8-fold decreased). Among validated genes, fatty acid synthase, stearoyl-CoA desaturase 1, fatty acid translocase/Cd36, malic enzyme, cholesterol-7 alpha hydroxylase, cadherin 17, and peroxisome proliferator-activated receptor alpha significantly correlated with severity of hepatic steatosis. In conclusion, dysregulated expression of metabolic and survival genes accompany hepatic steatosis in obese insulin-resistant rats and may render steatotic hepatocytes more vulnerable to cell injury in progressive nonalcoholic fatty liver disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19783528      PMCID: PMC2817580          DOI: 10.1194/jlr.M001966

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  43 in total

Review 1.  'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis.

Authors:  Amedeo Lonardo; Cesare Carani; Nicola Carulli; Paola Loria
Journal:  J Hepatol       Date:  2006-04-05       Impact factor: 25.083

Review 2.  Nutrition and metabolism: non-alcoholic fatty liver disease - pathogenesis, cardiovascular risk and therapy.

Authors:  Gerald F Watts; Seng Khee Gan
Journal:  Curr Opin Lipidol       Date:  2008-02       Impact factor: 4.776

Review 3.  Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis.

Authors:  Ignazio Grattagliano; Vincenzo O Palmieri; Piero Portincasa; Antonio Moschetta; Giuseppe Palasciano
Journal:  J Nutr Biochem       Date:  2007-09-12       Impact factor: 6.048

4.  Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis.

Authors:  Montserrat Marí; Francisco Caballero; Anna Colell; Albert Morales; Juan Caballeria; Anna Fernandez; Carlos Enrich; José C Fernandez-Checa; Carmen García-Ruiz
Journal:  Cell Metab       Date:  2006-09       Impact factor: 27.287

Review 5.  The adipocyte-myocyte axis in insulin resistance.

Authors:  Henrike Sell; Daniela Dietze-Schroeder; Jürgen Eckel
Journal:  Trends Endocrinol Metab       Date:  2006-11-03       Impact factor: 12.015

Review 6.  Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader
Journal:  Prog Lipid Res       Date:  2008-09-09       Impact factor: 16.195

Review 7.  Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism.

Authors:  M Mahmood Hussain; Paul Rava; Xiaoyue Pan; Kezhi Dai; Stephanie K Dougan; Jahangir Iqbal; Farrah Lazare; Irani Khatun
Journal:  Curr Opin Lipidol       Date:  2008-06       Impact factor: 4.776

8.  GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice.

Authors:  Hélène L Kammoun; Hervé Chabanon; Isabelle Hainault; Serge Luquet; Christophe Magnan; Tatsuro Koike; Pascal Ferré; Fabienne Foufelle
Journal:  J Clin Invest       Date:  2009-04-13       Impact factor: 14.808

9.  Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice.

Authors:  Makoto Miyazaki; Harini Sampath; Xueqing Liu; Matthew T Flowers; Kiki Chu; Agnieszka Dobrzyn; James M Ntambi
Journal:  Biochem Biophys Res Commun       Date:  2009-02-05       Impact factor: 3.575

10.  PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways.

Authors:  Huaiyu Mi; Nan Guo; Anish Kejariwal; Paul D Thomas
Journal:  Nucleic Acids Res       Date:  2006-11-27       Impact factor: 16.971

View more
  28 in total

1.  High-Fructose Intake Impairs the Hepatic Hypolipidemic Effects of a High-Fat Fish-Oil Diet in C57BL/6 Mice.

Authors:  Joshua S Wooten; Tayler N Nick; Andrew Seija; Kaylee E Poole; Kelsey B Stout
Journal:  J Clin Exp Hepatol       Date:  2016-09-08

2.  Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Intermediates of the Cholesterol Biosynthetic Pathway in Primary Cultured Rat Hepatocytes.

Authors:  Elizabeth A Rondini; Asmita Pant; Thomas A Kocarek
Journal:  J Pharmacol Exp Ther       Date:  2015-10-01       Impact factor: 4.030

3.  Dietary soy protein induces hepatic lipogenic enzyme gene expression while suppressing hepatosteatosis in obese female Zucker rats bearing DMBA-initiated mammary tumors.

Authors:  Reza Hakkak; Ahmed Al-Dwairi; George J Fuchs; Soheila Korourian; Frank A Simmen
Journal:  Genes Nutr       Date:  2012-04-24       Impact factor: 5.523

4.  Up-regulation of stearoyl-CoA desaturase 1 increases liver MUFA content in obese Zucker but not Goto-Kakizaki rats.

Authors:  Minako Karahashi; Fumiko Ishii; Tohru Yamazaki; Koichi Imai; Atsushi Mitsumoto; Yoichi Kawashima; Naomi Kudo
Journal:  Lipids       Date:  2013-03-29       Impact factor: 1.880

5.  Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression.

Authors:  Yue Li; Jibin Dong; Tingbo Ding; Ming-Shang Kuo; Guoqing Cao; Xian-Cheng Jiang; Zhiqiang Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-02       Impact factor: 8.311

Review 6.  The role of gastrointestinal hormones in hepatic lipid metabolism.

Authors:  Jamie Eugene Mells; Frank A Anania
Journal:  Semin Liver Dis       Date:  2013-11-12       Impact factor: 6.115

7.  Altered gene and protein expression in liver of the obese spontaneously hypertensive/NDmcr-cp rat.

Authors:  Jie Chang; Shinji Oikawa; Gaku Ichihara; Yui Nanpei; Yasuhiro Hotta; Yoshiji Yamada; Saeko Tada-Oikawa; Hitoshi Iwahashi; Emiko Kitagawa; Ichiro Takeuchi; Masao Yuda; Sahoko Ichihara
Journal:  Nutr Metab (Lond)       Date:  2012-09-21       Impact factor: 4.169

8.  High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway.

Authors:  Elena Bravo; Simonetta Palleschi; Patricia Aspichueta; Xabier Buqué; Barbara Rossi; Ainara Cano; Mariarosaria Napolitano; Begoña Ochoa; Kathleen M Botham
Journal:  Lipids Health Dis       Date:  2011-04-19       Impact factor: 3.876

9.  Bi-directional gene set enrichment and canonical correlation analysis identify key diet-sensitive pathways and biomarkers of metabolic syndrome.

Authors:  Melissa J Morine; Jolene McMonagle; Sinead Toomey; Clare M Reynolds; Aidan P Moloney; Isobel C Gormley; Peadar O Gaora; Helen M Roche
Journal:  BMC Bioinformatics       Date:  2010-10-07       Impact factor: 3.169

10.  Leucine and protein metabolism in obese Zucker rats.

Authors:  Pengxiang She; Kristine C Olson; Yoshihiro Kadota; Ayami Inukai; Yoshiharu Shimomura; Charles L Hoppel; Sean H Adams; Yasuko Kawamata; Hideki Matsumoto; Ryosei Sakai; Charles H Lang; Christopher J Lynch
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.